<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02456194</url>
  </required_header>
  <id_info>
    <org_study_id>RL007</org_study_id>
    <nct_id>NCT02456194</nct_id>
  </id_info>
  <brief_title>Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ross Leighton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biocomposites, Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective clinical trial of tibial plateau fractures treated with internal
      fixation and a calcium sulfate graft which can be mixed with antibiotics and molded into
      various bead sizes for implantation into bone defects. The graft material chosen for this
      study is STIMULAN Rapid Cure (Biocomposites, UK), which is approved for use as a bone void
      filler and may be mixed with a variety of antibiotics. The combination of STIMULAN +
      antibiotic in bead form is the &quot;study device&quot;.

      Our primary study aim is to look at resorption and remodeling of the study device into bone.
      Another important aim of the study is to look at subsidence, or collapse, of the joint
      surface.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resorption of Study device</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of study device remaining (visible on CT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Injury Osteoarthritis Outcome Score</measure>
    <time_frame>Baseline, 6 weeks, 3 months, 6 months, 12 months</time_frame>
    <description>Self-reported outcome score, reported as the change in score from baseline at each time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>6 weeks, 3 months, 6 months, 12 months</time_frame>
    <description>Range of knee motion (flexion-extension) in degrees</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resorption of Study device</measure>
    <time_frame>6 weeks, 3 months, 12 months</time_frame>
    <description>Percent of study device remaining (visible on plain x-ray)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subsidence of joint surface</measure>
    <time_frame>6 weeks, 3 months, 6 months, 12 months</time_frame>
    <description>Amount of collapse of the joint surface, measured in mm, on plain x-ray or CT scan</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Tibial Fractures</condition>
  <condition>Intra-Articular Fractures</condition>
  <condition>Fracture Fixation, Internal</condition>
  <arm_group>
    <arm_group_label>Calcium Sulfate + Antibiotics + Internal Fixation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Calcium Sulfate + Antibiotics + Internal Fixation</intervention_name>
    <description>STIMULAN Rapid Cure, mixed with antibiotic, and prepared in bead form. Must be used in conjunction with internal fixation. Choice of antibiotic is left to the surgeon's discretion.</description>
    <arm_group_label>Calcium Sulfate + Antibiotics + Internal Fixation</arm_group_label>
    <other_name>STIMULAN Rapid Cure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (skeletally mature) men or women;

          -  Acute, closed, tibial plateau fractures, Schatzker grade 1 through 5;

          -  Internal fixation and use of study device per protocol;

          -  Fracture repair within 30 days of injury;

          -  Signed informed consent to participate in study.

        Exclusion Criteria:

          -  Uncontrolled diabetes;

          -  Severe degenerative or metabolic bone disease;

          -  Malignancy;

          -  Severe vascular or neurologic disease;

          -  Alcoholism;

          -  Substance abuse;

          -  Use of systemic steroids;

          -  Immunosuppressive therapy;

          -  Hypercalcaemia;

          -  Renal-compromised patients;

          -  Osteomyelitis or chronic infection in the study limb;

          -  Women who are pregnant or breast-feeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ross Leighton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nova Scotia Health Authority</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alberta Health Services</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 1N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Horizon Health Network</name>
      <address>
        <city>Moncton</city>
        <state>New Brunswick</state>
        <zip>E1C6Z8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial University of Newfoundland</name>
      <address>
        <city>Saint John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1C5S7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Halifax Infirmary</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3h 1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital du Sacre-Coeur de Montreal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 26, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>May 23, 2019</last_update_submitted>
  <last_update_submitted_qc>May 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Ross Leighton</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
    <mesh_term>Intra-Articular Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

